Meritain Eldorado policies, page 3
Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
109 policies name 96413, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0912-Ustekinumab | 0912 · Commercial | 61 | Original policy ↗ |
| 0419-Graves' Ophthalmopathy Treatments | 0419 · Commercial | 62 | Original policy ↗ |
| 1009-Risankizumab-rzaa (Skyrizi) | 1009 · Commercial | 66 | Original policy ↗ |
| 1083-Nipocalimab-aahu (Imaavy) | 1083 · Commercial | 66 | Original policy ↗ |
| 0799-Tocilizumab | 0799 · Commercial | 81 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |
| Multiple Sclerosis | 0264 · Commercial | 126 | Original policy ↗ |
| 0161-Infusion Pumps | 0161 · Commercial | 151 | Original policy ↗ |
| 0715-Pharmacogenetic Testing | 0715 · Commercial | 231 | Original policy ↗ |